Business ❯Pharmaceutical Industry ❯Drug Development

Psychedelic Drugs

FDA Approval Process Lykos Therapeutics

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

The decision marks the first time the agency has considered a Schedule I psychedelic for medical use, highlighting ethical and safety concerns.

FDA Faces Critical Decision on MDMA Therapy for PTSD